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Abstract
Less than half of stool samples from people symptomatic with infectious intestinal disease
(IID) will identify a causative organism. A secondary data analysis was undertaken to explore
whether symptomology alone could be used to make inferences about causative organisms.
Data were utilised from the Second Study of Infectious Intestinal Disease in the
Community. A total of 844 cases were analysed. Few symptoms differentiated individual
pathogens, but grouping pathogens together showed that viral IID was more likely when
symptom onset was in winter (odds ratio (OR) 2.08, 95% confidence interval (CI)
1.16–3.75) or spring (OR 1.92, 95% CI 1.11–3.33), the patient was aged under 5 years (OR
3.63, 95% CI 2.24–6.03) and there was loss of appetite (OR 2.19, 95% CI 1.29–3.72). The
odds of bacterial IID were higher with diarrhoea in the absence of vomiting (OR 3.54, 95%
CI 2.37–5.32), diarrhoea which persisted for >3 days (OR 2.69, 95% CI 1.82–3.99), bloody
diarrhoea (OR 4.17, 95% CI 1.63–11.83) and fever (OR 1.67, 95% CI 1.11–2.53). Symptom
profiles could be of value to help guide clinicians and public health professionals in the man-
agement of IID, in the absence of microbiological confirmation.
Introduction
Infectious intestinal disease (IID) is characterised by the acute onset of diarrhoea and/or vomit-
ing in otherwise healthy people caused by an infectious, transmissible organism [1]. In the UK,
the surveillance of IID is based on statutory notifications, outbreak reports and syndromic sur-
veillance from primary, secondary and remote health services [2, 3]. However, as the syndrome
of diarrhoea and vomiting can have non-infectious causes, microbiological confirmation remains
central to conclusive diagnosis of IID. Although microbiological testing is the gold standard, in
some cohort studies, causative organisms have only been identified in 37–46% of samples from
symptomatic individuals [1, 4, 5]. The likelihood of identifying a causative organism has been
found to be affected by factors such as age, sex, occupation, the absence of specific symptoms
such as vomiting, and the timing of the stool sample in relation to symptom onset [1]. Other
factors such as the volume of the sample, the performance of the microbiological test and
local organism testing policies may also impact on the isolation of organisms [6, 7].
This diagnostic gap means that for over half of symptomatic patients, the cause of illness will
not be identified. Whilst the majority of IID cases are self-limiting, being aware of the underlying
cause can be of value in both case and outbreak management. For outbreak situations, epidemio-
logical criteria have been developed which utilise, among other factors, the proportion of people
affected by given symptoms in order to make inferences as to the underlying organism. The most
notable of these is the Kaplan criteria [8] which were developed in the 1980s in response to the
lack of diagnostic tests available for isolating norovirus. Kaplan identified that, where no bacterial
organism had been identified in stool cultures, outbreaks were more likely to be caused by nor-
ovirus when >50% of people were affected by vomiting; the incubation period was 24–48 h; and
the mean duration of illness was 12–60 h. A subsequent re-evaluation of these criteria, once
diagnostic tests became available, found them to be highly specific (99%) and moderately sen-
sitive (68%) at distinguishing outbreaks of norovirus from bacterial IID outbreaks [9]. Other epi-
demiological criteria have also been proposed, including a greater fever–vomiting ratio [10] and
a higher diarrhoea–vomiting ratio in bacterial outbreaks, suggesting that fever and diarrhoea are
more indicative of a bacterial cause [11]. However, the basis of epidemiological criteria is the
relative prevalence of symptoms occurring within a group of affected people, and as such
they cannot be applied to individual cases. Seasonal outbreaks of IID may present as an increase
in reporting of individual cases and therefore being able to ascribe likely cause to single cases of
IID has public health and epidemiological value, as well as clinical application. This study uses
data from a large community cohort and General Practice study to investigate whether
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symptoms alone can be used to make inferences as to the causative
organisms for individual cases of IID.
Methods
Data sources
A secondary data analysis was undertaken using data from the
Second Study of Infectious Intestinal Disease in the Community
(IID2 Study), the methodology of which is detailed elsewhere [1,
12]. This analysis included data from the two main components
of the IID2 study: the General Practice (GP) presentation study,
which was a 12-month prospective study of people consulting a
GP with symptoms of IID; and the prospective population-based
cohort study, which involved weekly follow-up of healthy volunteers
in the community to identify any symptoms of IID. The case defin-
ition for IID that was used in the original study was loose stools or
clinically significant vomiting lasting <2 weeks, in the absence of a
known non-infectious cause. Both studies utilised symptom ques-
tionnaires and stool sample testing of symptomatic people who
met the case definition. Cases were included in this analysis if
they had completed a symptom questionnaire and submitted a
stool sample. Cases with negative stool samples, where no pathogen
was identified, were excluded. Data from dual and triple infections
were included multiple times; once for each organism identified,
as the primary cause of symptoms could not be determined.
Data analysis
Multivariable logistic regression was used to determine the odds of
a case being caused by a given pathogen based on reported symp-
toms. The explanatory variables included the symptoms outlined
in the IID2 study symptom questionnaire, along with the partici-
pant’s age and date of symptom onset (Table 1). Continuous data,
namely symptom duration, date of illness onset and age, were cate-
gorised before inclusion in the regression models. Given that diar-
rhoea and vomiting are the predominant symptoms of IID and
many people will have both, variables were created to capture
cases of diarrhoea in the absence of vomiting, and vomiting in
the absence of diarrhoea. These variables were used to explore
whether this is a symptom profile which offers discrimination
between pathogens. Phi coefficients were used to identify any sig-
nificant correlations between the explanatory variables which
might lead to mathematical problems with model fitting.
The outcome variable was the presence of the infectious organism.
Pathogenswhich accounted for>10%of the total numberof caseswere
analysed independently, to identify symptoms which distinguished
them from any other cause of IID. Below this threshold, case numbers
were too small to generate meaningful output for a single organism.
Grouped organism models were used to capture differences between
the broader classes of pathogen; bacteria, viruses and protozoa,
sequentially comparing one class against any other cause of IID.
Statistical analysis was undertaken in R 3.3.2 [13]. Odds ratios
(OR) were calculated using binomial backward stepwise regres-
sion. Models were selected based on the Akaike information cri-
terion (AIC). Upper and lower 95% confidence intervals (CI) were
calculated around each estimate.
Results
There was a total of 1657 cases identified from the IID2 study
which met the IID2 case definition and had both completed a
questionnaire and submitted a stool sample. Of these, 898 cases
(54%) were excluded from the analysis as no organism was iden-
tified from their stool sample. The total sample size for analysis
was 844; including 69 dual infections and eight triple infections.
Norovirus was the most commonly identified cause of IID, and
campylobacter was the commonest bacterial cause (Table 2). Only
four pathogens met the criteria for organism-specific analysis;
norovirus, campylobacter, rotavirus and sapovirus. The total
number of protozoal infections was <10% of the total number
of cases and consequently grouped organism models were only
generated for bacterial and viral IID. To capture any important
differences in symptoms, protozoa were included in the compari-
son group for both the bacterial and viral models.
The grouped organism models (Table 3) showed that the odds
of the causative organism being bacterial were higher with diar-
rhoea in the absence of vomiting (OR 3.54, 95% CI 2.37–5.32),
diarrhoea which persisted for >3 days (OR 2.69, 95% CI
1.82–3.99), bloody diarrhoea (OR 4.17, 95% CI 1.63–11.83) and
fever (OR 1.67, 95% CI 1.11–2.53). The odds of a viral cause of
illness were higher when symptom onset was in winter (OR
2.08, 95% CI 1.16–3.75) or spring (OR 1.92, 95% CI 1.11–3.33),
the patient was under 5 years of age (OR 3.63, 95% CI 2.24–
6.03) and there was loss of appetite (OR 2.19, 95% CI 1.29–
3.72). Given protozoa have a similar aetiology to bacterial IID,
as contrasted to viral IID, the analysis was repeated with protozoa
assigned to the bacterial group to explore what impact this would
have on the symptom profiling. The resulting viral and bacterial/
protozoal models did not differ significantly from the above
Table 1. Explanatory variables included in the multivariate analysis and their
coding
Explanatory variables Coding
Symptoms from IID2
questionnairea
Diarrhoea days >3 days = 1 ⩽3 days = 0
Bloody diarrhoea Yes = 1 No = 0
Vomiting days >3 days = 1 ⩽3 days = 0
Nausea Yes = 1 No = 0
Nausea days >3 days = 1 ⩽3 days = 0
Abdominal pain Yes = 1 No = 0
Loss of appetite Yes = 1 No = 0
Fever Yes = 1 No = 0
Headache Yes = 1 No = 0
Cough/nose/throat Yes = 1 No = 0
Combined symptom variables
Diarrhoea but no vomiting Yes = 1 No = 0
Vomiting but no diarrhoea Yes = 1 No = 0
Participant characteristics
Ageb >16 years = 0, 5–16 years = 1,
<5 years = 2
Date of onsetb Autumn(0), Winter(1), Spring(2),
Summer(3)c
a‘Not sure’ responses from the original questionnaires were left blank and treated as
missing data.
bCoded as factors for analysis.
cSeasons defined by meteorological calendar.
2 A. L. Donaldson et al.
https://doi.org/10.1017/S0950268819001201
Downloaded from https://www.cambridge.org/core. Newcastle University, on 08 Aug 2019 at 10:07:40, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
models; the same explanatory variables were identified, but the
significance of winter and spring in the bacteria/protozoa model
was increased.
The organism-specific modelling generated less meaningful
outputs. The campylobacter model largely mirrored the grouped
bacterial model and did not provide any further discriminatory
information. The virus-specific analysis for norovirus, rotavirus
and sapovirus was sensitive to changes in the parameters of the
models which led to inconsistent symptom profiles. Phi coeffi-
cients were used to identify any significant correlations between
the binary explanatory variables which could impact on the
model fitting. There was no evidence of significant co-linearity
which would affect the modelling, although there were some
mild-to-moderate correlations (phi coefficient <0.5) between
some symptoms such as nausea and loss of appetite.
Discussion
This study has identified that people with IID who reported symp-
toms of diarrhoea in the absence of vomiting, diarrhoea lasting for
more 3 days, bloody diarrhoea and fever were at increased odds of
having a bacterial pathogen. Young age (<5 years), onset in spring
or winter and loss of appetite were associated with increased odds
of viral cause. These findings are consistent with other studies
which have found associations between bacterial pathogens and
symptoms of fever, bloody diarrhoea and prolonged illness, whilst
vomiting and a short duration of symptoms have been associated
with viral causes [14–17]. Epidemiological criteria, utilised in out-
break situations, have similarly highlighted the importance of
vomiting and short duration of illness as indicative of norovirus,
whilst symptoms such as fever and diarrhoea have been associated
with bacterial outbreaks [8–11]. This study is largely consistent
with these criteria, identifying similar associations between these
symptoms and the class of the underlying pathogen. However,
our analysis would suggest that vomiting and a short duration of
symptoms are better ascribed to viral IID than any single viral
pathogen. Furthermore, the duration of norovirus symptoms is
known to be affected by individual risk factors, such as hospitalisa-
tion and age [18, 19]. Therefore, the 12–60 h duration used in the
Kaplan criteria may be less applicable when considering individual
cases of norovirus illness. This study used ⩽3 days to categorise
symptom duration, which provided good discrimination between
bacterial and viral causes of IID.
This analysis did not identify symptoms which could be used
to adequately differentiate individual IID pathogens. This should
act as a caution against making assumptions about the underlying
organism on the basis of symptoms alone. However, this dataset
did not contain sufficient numbers of some organisms to generate
the statistical power necessary to model at the level of individual
pathogens. Furthermore, the mild-to-moderate correlations iden-
tified between certain symptoms could make it harder for statis-
tical models to distinguish individual pathogens on the basis of
these symptoms alone.
The findings of this study have application for clinicians, pub-
lic health professionals and epidemiologists, who use symptoms
to generate hypotheses regarding causative organisms when man-
aging cases and outbreaks of IID. This analysis would suggest that
assumptions should not be made as to the individual pathogen in
the absence of microbiological confirmation. However, given the
different transmission patterns and natural histories of bacterial
and viral IID [20], using symptom profiles to indicate a likely bac-
terial or viral cause could assist the early stages of outbreak inves-
tigations when microbiology is not yet available. This could help
guide infection prevention and control; for example, viral causes
are more likely to be spread person to person, whereas bacterial
IID would raise suspicion of a food or animal contact. Given
the large diagnostic gap for IID, the role of symptoms is still of
vital importance to guide clinical and public health action.
These findings could have further application for syndromic sur-
veillance systems, enabling symptomatic cases to be categorised as
either suspected bacterial or viral IID. However, the benefits of
this would have to be weighed against the practical challenges
of developing sensitive and specific case definitions that would
Table 2. Organisms and the associated number of cases, as included in the
analysis
Pathogen No. cases identified
Bacteria 238
C. difficile 11
C. perfringens 25
Campylobacter sp. 150
E.coli VTEC 15
Enteroaggregative E.coli 27
Salmonella sp. 9
Yersinia sp. 1
Viruses 576
Adenovirus 58
Astrovirus 36
Norovirus 237
Rotavirus 96
Sapovirus 149
Protozoa 30
Cryptosporidium sp. 15
Giardia sp. 15
Total organisms identified 844
Table 3. Grouped organism multivariate model outputs (OR with 95%
confidence intervals) for bacterial and viral pathogens, as compared to any
other pathogen
Explanatory variable
Odds ratio (95% confidence intervals)
Bacterial Viral
Aged <5 years 0.25 (0.14–0.41) 3.63 (2.24–6.03)
Onset in winter 0.65 (0.35–1.19) 2.08 (1.16–3.75)
Onset in spring 0.70 (0.40–1.23) 1.92 (1.11–3.33)
Diarrhoea but no vomiting 3.54 (2.37–5.32) 0.27 (0.18–0.39)
Bloody diarrhoea 4.17 (1.63–11.83) 0.30 (0.11–0.79)
Diarrhoea lasting >3 days 2.69 (1.82–3.99) 0.33 (0.22–0.48)
Loss of appetite 0.44 (0.26–0.75) 2.19 (1.29–3.72)
Fever 1.67 (1.11–2.53) 0.59 (0.39–0.88)
Epidemiology and Infection 3
https://doi.org/10.1017/S0950268819001201
Downloaded from https://www.cambridge.org/core. Newcastle University, on 08 Aug 2019 at 10:07:40, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
be compatible with the level of symptom detail gathered and
recorded by syndromic surveillance systems [21].
Strengths and limitations
This study utilised data from a large prospective cohort study [12],
removing some of the reporting biases inherent within national
surveillance data [22]. However, given that the severity and dur-
ation of illness is known to affect health-seeking behaviour and
stool sample submission [22], mild short-lived illness is still likely
to be underrepresented in these data. Despite the large size of the
dataset, the total numbers of some organisms were too low to
allow organism-specific models to be developed for all but the
four most common causes. Furthermore, protozoa could not be
examined as a separate class of pathogen due to small numbers.
In this analysis, protozoa were included in the comparison
group for both the bacterial and viral models. To explore the
impact this could have had on the modelling, the analysis was
repeated with protozoa assigned to the bacterial group. The result-
ing viral and bacterial/protozoal models did not differ significantly
from the original models indicating that the group allocation of
the protozoa had little impact on the findings of this analysis.
It should be considered that the grouped organism profiles will
be naturally weighted by the relative prevalence of different organ-
isms within each class; campylobacter accounted for almost
two-thirds of all the bacterial cases and norovirus accounted for
over 40% of viral cases. Consequently, the bacterial and viral mod-
els will disproportionality reflect the symptoms associated with
these pathogens. However, this reflects real-life diagnostics where
certain symptoms or organisms are more likely simply because
they occur more commonly. Whilst this analysis could not identify
symptom profiles which discriminated individual pathogens, this is
an area that warrants further exploration. Future studies could also
consider the role of co-infections, as co-infections have been found
to affect the pathogenicity of organisms [23].
Conclusion
Symptom profiles could be used to help dissociate between bacter-
ial and viral causes of IID however, symptoms do not allow further
discrimination of individual organisms. Microbiology remains the
gold standard and where possible, microbiological confirmation
is recommended. However, in situations where microbiology is
not available or results are inconclusive, symptom profiling could
be of value for clinicians, public health professionals and epide-
miologists to distinguish likely bacterial and viral pathogens to
guide the management of cases and outbreaks of IID.
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